Kansai Medical University Hospital ( Site 3016)

Hirakata, Osaka 573-1191

0 studies enrolling now · 1 studies all time

What they study most

Non-Small Cell Lung Cancer

Studies at this site

• Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86) — Running, not enrolling